1 Introduction
In recent years, England and Wales have been experiencing a reduction in the
annual improvements in all-cause mortality rates. This study uses cause-specific
mortality experience to investigate the observed slowdown in these annual im-
provements in all-cause mortality. The aim of the study is to quantify the
contributions of different causes of death towards the reduction in mortality rate
improvements, and also to investigate life expectancies under various scenarios
for cause-specific mortality rate trends. Aiming at enhancing the understanding
of the slowdown in all-cause mortality improvements, cause-specific scenarios
are generated in order to explore the differences in mortality rate improvements
that are observed, compared to improvements in scenarios where cause-specific
trends are reverted to pre-slowdown levels. These cause-specific scenarios are
useful for the purpose of investigating what would have happened if the trends
for certain causes of death had remained the same throughout the observed
slowdown in mortality improvements. The use of scenarios is a novel approach
for quantifying cause-specific contributions. Investigating the impact of individ-
ual causes towards the slowdown in mortality improvements is important for
better understanding of the drivers of increasing human longevity.
Many countries in the world have experienced improvements in life expectancy
throughout the 20th century into the 21st century. A number of authors have
noted that reductions in infectious disease and infant mortality have led to
the greatest amount of improvements in life expectancy in the first half of
the 20th century for Europe and North America (Wilmoth, 2000; Oeppen and
Vaupel, 2002; Cutler, Deaton, and Lleras-Muney, 2006; Leon, 2011; Mackenbach
and Looman, 2013). In the United States and Western European countries,
improvements in cardiovascular disease mortality at older ages led to the contin-
ued improvement in life expectancies after 1970 (Tuljapurkar and Boe, 1998;
Wilmoth, 2000; Levi, Lucchini, Negri, and La Vecchia, 2002; Oeppen and Vaupel,
2002; Cutler, Deaton, and Lleras-Muney, 2006; Leon, 2011; Mackenbach and
Looman, 2013). However, Eastern European countries experienced increasing
levels of cardiovascular disease mortality (Levi, Lucchini, Negri, and La Vecchia,
2002; Leon, 2011), which led to slower gains and even worsening of life expectan-
cies (Leon, 2011). The improvement in cardiovascular disease mortality was
linked to improvements in risk factors and in treatments (Levi, Lucchini, Negri,
and La Vecchia, 2002; O’Flaherty, Ford, Allender, Scarborough, and Capewell,
2008; Scholes, Bajekal, Love, Hawkins, Raine, O’Flaherty, and Capewell, 2012).
Mackenbach and Looman (2013) also suggested that the improvement in cardio-
vascular mortality at older ages might be related to the national income of a
country.
England and Wales have also experienced similar reductions in infectious
disease and cardiovascular disease mortality during the 20th century (Griffiths
and Brock, 2003; O’Flaherty, Ford, Allender, Scarborough, and Capewell, 2008).
Along with improvements in cardiovascular disease mortality, England and
Wales have shown changing trends in associated risk factors. O’Flaherty et al.
(2008) and Scholes et al. (2012) noted reductions in smoking prevalence, but
also increases in the prevalence of obesity and diabetes. While improvements
in cardiovascular disease mortality continued to occur at older ages, the rate
2